October 2025 - Page 22 of 28

WednesdayOct 08, 2025 11:55 am

QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Begins On-Site Validation at Planta Magdalena Project in Colombia

This article has been disseminated on behalf of ESGold and may include a paid advertisement. ESGold (CSE: ESAU) (OTCQB: ESAUF) announced that its geological and engineering team has arrived in Colombia to begin on-the-ground validation and due diligence at the Planta Magdalena Project, following the memorandum of understanding signed Aug. 20, 2025. The field program aims to confirm historic tailings grades, assess site infrastructure and throughput potential, and evaluate exploration opportunities across the Bolívar concession area. Bulk samples from both Colombia and Quebec have been shipped to ALS Global in Val-d’Or for metallurgical testing to verify gold and silver recoveries under…

WednesdayOct 08, 2025 11:15 am

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Expands Commercialization Strategy with $375K Financing, Investor Awareness Agreements, and Breakthrough Personalized Radiation Dose Breast CT

Izotropic Corp. marks a significant milestone in breast imaging with its patent-pending personalized radiation dose feature with the IzoView Breast CT system Recently, the company secured a $375,000 non-brokered private placement to help with core operations in addition to engaging new PR partners for improved investor communications With projections for global breast imaging expected to hit $8.69 billion by 2030, the company is poised to strategically dominate the market Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a leading medical device firm in the field of breast cancer imaging solutions, is speeding up its efforts towards commercializing its innovations. Izotropic recently…

WednesdayOct 08, 2025 10:36 am

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Need for Advanced 3D Imaging During Breast Cancer Awareness Month

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based technologies for more accurate breast cancer screening, diagnosis, and treatment, marked Breast Cancer Awareness Month by emphasizing the limitations of current imaging tools and the significant opportunity for its flagship IzoView Breast CT Imaging System. With more than 2.3 million new breast cancer cases reported globally each year—and over 315,000 expected in the U.S. in 2025—Izotropic underscored the urgent need for true high-resolution 3D imaging, especially for women with dense breast tissue, which affects roughly 50% of women and diminishes the accuracy of compression-based screening. As the…

WednesdayOct 08, 2025 10:30 am

Oncotelic Therapeutics Inc.’s (OTLC) Sapu003: Injectable Everolimus (Afinitor(R)) to Begin Clinical Trials, Aiming to Boost Drug Bioavailability

Oncotelic Therapeutics developed the Deciparticles(TM) technology to improve the bioavailability of drugs, largely thanks to the creation of sub-20nm size of the nanoparticles Sapu Nano, part of Oncotelic’s GMP Bio joint venture, receives clearance to begin Phase 1 trial of Sapu003, an injectable form of Everolimus (Afinitor(R)) for breast cancer In preclinical studies, Sapu003 could raise the bioavailability of Everolimus (Afinitor(R)) from around 10%, as oral pill, up to anywhere from 80 to 100%, as injectable Result hopes for higher bioavailability in that drugs may have dramatically better, faster, and more consistent efficacy for patients Oncotelic Therapeutics (OTCQB: OTLC) is…

WednesdayOct 08, 2025 10:16 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Announces Phase 1 Trial of Sapu-003, a Novel Intravenous Deciparticle(TM) Everolimus, Now Open for Enrollment in Australia

Oncotelic Therapeutics (OTCQB: OTLC), through its joint venture GMP Biotechnology Ltd. with Dragon Overseas Capital Ltd., announced that Sapu Nano presented its poster, “Sapu-003: Novel Intravenous Deciparticle(TM) Everolimus Entering Phase 1 Study in Australia,” at the 8th Australian Translational Breast Cancer Research Symposium (ATBCR 2025). The study marks the first clinical trial of an intravenous Deciparticle(TM) formulation of everolimus, an mTOR inhibitor used in breast cancer and other malignancies. Conducted in collaboration with SOCRU, Ingenū, and Medicilon, the trial (ACTRN12625001083482) is now enrolling patients with advanced HR+/HER2– breast cancer or other mTOR-sensitive tumors at leading oncology centers across Australia. “Sapu-003…

WednesdayOct 08, 2025 9:55 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

Nutriband (NASDAQ: NTRB) announced that Chairman Serguei Melnik will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Wednesday, Oct. 8, 2025, at 3 p.m. ET. The presentation will include a fireside Q&A session with questions from the live virtual audience, and registered investors can also schedule one-on-one meetings with Melnik. Interested attendees can register at no cost via the conference’s official site. A video webcast of the presentation will be available on Channelchek, Noble’s investor portal, and archived for 90 days on both Channelchek.com and Nutriband’s website. To view the full press release, visit https://ibn.fm/UjUSO About Nutriband…

WednesdayOct 08, 2025 9:52 am

QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Stock Surges on Reported 10% Trump Administration Stake and EO for Ambler Road Permits

A Yahoo! Finance article by Jake Conley reported that Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) surged more than 200% after news that the Trump administration purchased a 10% equity stake valued at $35.6 million, with warrants for an additional 7.5% interest. The article detailed that President Trump also signed an executive order instructing federal agencies to reinstate and approve all required permits for the Ambler Access Project, a 211-mile industrial road that would connect Alaska’s mineral-rich Ambler Mining District to the state highway system. The district hosts substantial deposits of copper, cobalt, silver, gold, lead, and other critical metals…

WednesdayOct 08, 2025 9:45 am

Newton Golf Company (NASDAQ: NWTG) Meets High Standards in Golf Equipment Quality

Investing in quality golf equipment can have a profound impact on a player’s game. Newton Golf’s quality product offerings include innovations such as the Fast Motion Driver Shaft and the Newton’s Gravity Putters. Players who select thoughtfully designed, technologically advanced clubs gain measurable improvements in performance, confidence and enjoyment. For golfers aiming to elevate their performance, the equipment they choose can make all the difference. Newton Golf Company (NASDAQ: NWTG) is at the forefront of this philosophy, offering precision-engineered clubs and accessories designed to help players achieve consistency, power and control. The company’s dedication to innovation and quality has established…

WednesdayOct 08, 2025 9:33 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Positions for Quantum-Era Growth with Launch of Four Digital Asset Exchanges

Datavault AI (NASDAQ: DVLT) is redefining how technology and capital converge, turning its Q4 update into a blueprint for a new digital exchange economy. The company has established four Delaware corporations—the International Elements Exchange, International NIL Exchange, Information Data Exchange, and American Political Exchange—each designed to trade tokenized and stable assets beyond the reach of traditional markets. With regulatory clarity from Washington’s Clarity and Genius Acts paving the way, Datavault expects two of these exchanges to go live before year-end 2025, reflecting what management calls “growth by intention.” By aligning artificial intelligence, blockchain, and quantum computing into one scalable system,…

WednesdayOct 08, 2025 9:20 am

QualityStocksNewsBreaks – GlobalTech Corp. (OTC: GLTK) President Frank R. Parrish III Featured on IBN’s TechMediaWire Podcast

GlobalTech (OTC: GLTK), a U.S.-based technology holding company specializing in artificial intelligence, big data, and digital infrastructure, is featured in the latest episode of The TechMediaWire Podcast produced by IBN, a multifaceted communications organization connecting public companies with the investment community. In the episode, GlobalTech President Frank R. Parrish III discusses the company’s mission to create value through collaboration and technology-driven innovation, outlining its dual-vertical strategy that combines proprietary AI and big data product development with value-added acquisitions. Parrish also highlights GlobalTech’s rapid global expansion, with active operations across the United States, the United Kingdom, the European Union, the Middle…

Site Search

Company Search

Month: October 2025